Skip to main content
Signal8
Ciaffoni Joseph profile photo

Joseph Ciaffoni

CIK: 0001443841

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)1 (33.3%)

Derivative conversions

Awards (A)1 (33.3%)

Compensation grants

Other (G, F, J, C, D, …)1 (33.3%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Indivior Pharmaceuticals, Inc. logo
INDV

Indivior Pharmaceuticals, Inc.

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (3 total)

  • Indivior Pharmaceuticals, Inc. logo
    INDV

    Indivior Pharmaceuticals, Inc.

    Jun 22, 2026
    Exercise(M)
    Direct
    1.3M shares-
  • Indivior Pharmaceuticals, Inc. logo
    INDV

    Indivior Pharmaceuticals, Inc.

    Jun 22, 2026
    Tax Payment(F)
    Direct
    612.5K shares at avg. $38.32$23.5M
  • Indivior Pharmaceuticals, Inc. logo
    INDV

    Indivior Pharmaceuticals, Inc.

    Feb 10, 2026
    Award(A)
    Direct
    80K shares-

1-3 of 3

About Ciaffoni Joseph

Ciaffoni Joseph (SEC CIK 0001443841) files insider reports with the SEC as Chief Executive Officer of Indivior Pharmaceuticals, Inc. (INDV).

Signal8 holds 3 ownership filings by Ciaffoni Joseph (1 Form 3, 2 Form 4), filed between Jan 7, 2026 and Jun 23, 2026. Those filings report 3 transactions, from Feb 10, 2026 to Jun 22, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Ciaffoni Joseph's filings is in NORTH CHESTERFIELD, VA.

Recent filings by Ciaffoni Joseph

  • Jun 22, 2026: Option exercise of INDV shares (Form 4, code M).
  • Jun 22, 2026: Tax withholding of INDV shares (Form 4, code F).
  • Feb 10, 2026: Grant or award of INDV shares (Form 4, code A).

Other insiders filing for Indivior Pharmaceuticals, Inc. (INDV)

How to read Form 4 transaction codes